WE ARE A PEDIATRIC, RARE
PHARMACEUTICAL DEVELOPMENT COMPANY
IS DEDICATED TO YOU.
Welcome to Asklepion Pharmaceuticals.
Asklepion is focused on the discovery, development, and commercialization of pharmaceutical products to help patients who have little to no therapeutic options, due to the rarity of their conditions. Read more about the company here.
L-citrulline pivotal Phase III trial initiated in July 2016
Liquid formulation of ursodeoxycholic acid strategically divested to Retrophin, Inc. in June 2016.